Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy.
about
The role of long chain fatty acids and their epoxide metabolites in nociceptive signalingPossible role of Epoxyeicosatrienoic acid in prevention of oxidative stress mediated neuroinflammation in Parkinson disordersThe 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic painIdentification of a novel spinal nociceptive-motor gate control for Aδ pain stimuli in rats.Gabapentin alleviates affective pain after traumatic nerve injury.Endoplasmic reticulum stress in the peripheral nervous system is a significant driver of neuropathic pain.Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes.Breaking barriers to novel analgesic drug development.Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases.Soluble epoxide hydrolase inhibition alleviates neuropathy in Akita (Ins2 Akita) mice.Epoxy fatty acids mediate analgesia in murine diabetic neuropathy.Inhibition of soluble epoxide hydrolase attenuates eosinophil recruitment and food allergen-induced gastrointestinal inflammation.Metabolic/inflammatory/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target.Inhibition of Soluble Epoxide Hydrolase 2 Ameliorates Diabetic Keratopathy and Impaired Wound Healing in Mouse Corneas.
P2860
Q28248377-109CE0E7-F2B8-4C44-8795-20CE5F61AAE6Q28386662-AFED3FE1-3877-4FED-AB0C-0B63392A269EQ28392416-228F3E4D-19DB-4F6A-B4B5-B0DFD64584CBQ33798019-2F2FFDD2-D1B8-4C7F-87B3-F4AA27D5B7E8Q35776426-290C8522-24C4-45BE-8EB6-C51ACECAEAD7Q35895730-4E4531DA-F650-42AA-970C-95735B94A122Q36684873-E6FF804A-B410-4833-8175-5D74392CF391Q39360773-01B04AE3-D208-4EDF-AFAC-40E77525C511Q39392465-5D33EA4D-5B20-439B-8FB8-18058CD1004DQ46614540-AEE49E36-1051-47F3-8949-EC97B110E1F7Q46708671-21892103-D972-4D9B-ABE8-6F707790D37FQ49972956-6B62C1EE-6D77-455C-AA86-BFC5BBBAC787Q50175494-6DEAD966-FEDE-48FD-B27F-B5A37E4DDEA9Q52609150-007E22B3-A6B0-427A-881A-9FC6E65E82BF
P2860
Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Soluble epoxide hydrolase inhi ...... model of diabetic neuropathy.
@ast
Soluble epoxide hydrolase inhi ...... model of diabetic neuropathy.
@en
Soluble epoxide hydrolase inhi ...... model of diabetic neuropathy.
@nl
type
label
Soluble epoxide hydrolase inhi ...... model of diabetic neuropathy.
@ast
Soluble epoxide hydrolase inhi ...... model of diabetic neuropathy.
@en
Soluble epoxide hydrolase inhi ...... model of diabetic neuropathy.
@nl
prefLabel
Soluble epoxide hydrolase inhi ...... model of diabetic neuropathy.
@ast
Soluble epoxide hydrolase inhi ...... model of diabetic neuropathy.
@en
Soluble epoxide hydrolase inhi ...... model of diabetic neuropathy.
@nl
P2860
P1433
P1476
Soluble epoxide hydrolase inhi ...... model of diabetic neuropathy.
@en
P2093
Bruce D Hammock
Karen Wagner
P2860
P304
P356
10.1016/J.JPAIN.2014.05.008
P577
2014-06-09T00:00:00Z